Close

PVCT Financial Facts

Net loss applicable to common shareholders: -8.86M
Investment income: 318
See Full Income Statement

Warrant liability: 3.34M
Total Liabilities And Stockholders' Equity: 10.69M
See Full Balance Sheet

Provectus Biopharma (PVCT) Earnings

  |   Expand Research on PVCT
Next EPS Date 5/7/24 EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/7/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
2/28/24 Q423 N/AN/A N/A N/AN/A N/A N/A N/A
11/10/23 Q323 N/AN/A N/A N/AN/A N/A N/A N/A
11/13/23 Q323 N/AN/A N/A N/AN/A N/A N/A N/A
8/9/23 Q223 N/AN/A N/A N/AN/A N/A N/A N/A
8/28/23 Q223 N/AN/A N/A N/AN/A N/A N/A N/A
8/21/23 Q223 N/AN/A N/A N/AN/A N/A N/A N/A
5/9/23 Q123 N/AN/A N/A N/AN/A N/A N/A N/A